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Modelling cost-effective therapies
To the Editor: In the present era of rapidly increasing medical 
costs, there is a need for doctors to assist in controlling these costs, 
in addition to providing quality care to all patients. This requires 
inclusion of the parameter of ‘value’ in medical practice. Value has 
been defined as ‘outcome divided by costs’.[1]
In Fig. 1, a model of the changes in outcome with increasing 
costs is proposed. According to the model, the change follows a 
sigmoid curve pattern. This pattern is widely observed in biology, 
e.g. the dose-response effect to irradiation or chemotherapy
in oncology, and is also seen in the diffusion of innovation in
economics.
The model is semiquantitative and does not specify the 
endpoint for outcome on the vertical axis or the cost in numbers 
on the horizontal axis. The endpoint used for outcomes will vary 
depending on the disease being treated. For example, in oncology 
the endpoints may be overall survival or quality of life parameters. 
The cost will vary depending on the therapeutic options available.
As can be seen in the model, value is initially low (A - B in Fig. 1), 
then increases (B - C), and then decreases again (C - D).
In cost-effective practice, doctors would seek to use the 
relatively high-value therapies between the threshold points on 
Fig. 1 (B - C) and avoid the low-value therapies. There would 
be a ‘sweet spot’ with maximum outcome and a high value at 
point C.
This model has been helpful in discussions by the author and others 
on the inclusion of different therapeutic interventions in treatment 
protocols, as it provided a framework for debate. Although the model 
is semiquantitative, agreement could readily be arrived at regarding on 
which part of the curve a proposed therapeutic intervention might fit.
The decision to include a therapeutic intervention in available 
treatment protocols will also need to include other factors, such 
as affordability. For example, the new biological therapies for 
melanoma[2] prolong survival, but are too expensive to use on a 
population-wide basis.
Funding in medicine is most often described from the 
perspective of medical schemes, government and industry. 
This needs to be complemented by the perspective of doctors 
who use their available resources to formulate cost-effective 
treatment protocols. The model may be helpful to doctors in joint 
undertakings with funders to provide quality care to patients and 
control costs.
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Fig. 1. A model for the change in outcome with increasing costs. (Value = 
outcome/costs.)
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